Koninklijke Philips N.V.(PHG)Earnings, Financials & Key Ratios
PHG•NYSE
$27.23
$25.9B mkt cap·24.9× P/E·Price updated May 6, 2026
AboutKoninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.Show more
- Revenue$17.83B-1.0%
- EBITDA$2.55B+32.9%
- Net Income$895M+227.5%
- EPS (Diluted)0.93+224.0%
- Gross Margin45.18%+4.8%
- EBITDA Margin14.29%+34.3%
- Operating Margin7.98%+172.0%
- Net Margin5.02%+228.8%
- ROE7.77%+233.4%
- ROIC6.39%+178.9%
- Debt/Equity0.74+18.3%
- Interest Coverage4.56+233.8%
PHG Key Insights
Koninklijke Philips N.V. (PHG) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 7/9
- ✓High quality earnings: Operating CF exceeds net income
✗Weaknesses
- ✗Thin 5Y average net margin of 1.8%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
PHG Price & Volume
Koninklijke Philips N.V. (PHG) stock price & volume — 10-year historical chart
Loading chart...
PHG Growth Metrics
Koninklijke Philips N.V. (PHG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-3.02%
5 Years0.59%
3 Years0.01%
TTM-1.04%
Profit CAGR
10 Years3.33%
5 Years-5.49%
3 Years-
TTM227.49%
EPS CAGR
10 Years3.49%
5 Years-5.44%
3 Years-
TTM224%
Return on Capital
10 Years4.42%
5 Years1%
3 Years3.02%
Last Year7.07%
PHG Recent Earnings
Koninklijke Philips N.V. (PHG) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 6/12 qtrs (50%)
Q1 2026Latest
Feb 10, 2026EPS
$0.70
Est $0.56
+23.9%
Revenue
$6.1B
Est $5.9B
+3.1%
Q4 2025
Nov 4, 2025EPS
$0.37
Est $0.37
+0.0%
Revenue
$5.0B
Est $5.0B
+0.1%
Q3 2025
Jul 29, 2025EPS
$0.41
Est $0.32
+29.2%
Revenue
$5.1B
Est $4.3B
+18.7%
Q2 2025
May 6, 2025EPS
$0.27
Est $0.14
+92.9%
Revenue
$4.6B
Est $4.6B
+1.9%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 10, 2026 | $0.70vs $0.56+23.9% | $6.1Bvs $5.9B+3.1% |
| Q4 2025 | Nov 4, 2025 | $0.37vs $0.37+0.0% | $5.0Bvs $5.0B+0.1% |
| Q3 2025 | Jul 29, 2025 | $0.41vs $0.32+29.2% | $5.1Bvs $4.3B+18.7% |
| Q2 2025 | May 6, 2025 | $0.27vs $0.14+92.9% | $4.6Bvs $4.6B+1.9% |
Based on last 12 quarters of dataView full earnings history →
PHG Peer Comparison
Koninklijke Philips N.V. (PHG) competitors in Imaging, radiation, and oncology devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SYK | 111.96B | 292.33 | 34.80 | 11.16% | 12.92% | 15.04% | 0.66 | |
 BSX | 83.23B | 56.00 | 28.87 | 19.87% | 14.4% | 12.4% | 0.51 | |
 EW | 47.97B | 83.20 | 45.46 | 11.55% | 17.64% | 10.35% | 0.07 | |
 BAX | 8.77B | 16.98 | -9.70 | 5.72% | -9.7% | -16.5% | 1.64 | |
 ZBH | 16.22B | 82.83 | 23.33 | 7.2% | 9.05% | 5.77% | 0.59 | |
 MDT | 99.48B | 77.60 | 21.50 | 3.62% | 13% | 9.45% | 0.59 | |
 GE | 319.54B | 305.83 | 37.48 | 18.48% | 17.91% | 45.85% | 1.08 | |
 GEHC | 28.08B | 61.74 | 13.57 | 4.84% | 7.54% | 14.45% | 0.94 |
Compare PHG vs Peers
Koninklijke Philips N.V. (PHG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PHG Income Statement
Koninklijke Philips N.V. (PHG) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 17.78B | 18.12B | 17.15B | 17.31B | 17.16B | 17.83B | 18.17B | 18.02B | 17.83B |
| Revenue Growth % | -27.48% | 1.92% | -5.38% | 0.97% | -0.91% | 3.91% | 1.92% | -0.81% | -1.04% |
| Cost of Goods Sold | 9.6B | 9.57B | 9.2B | 9.4B | 9.99B | 10.63B | 10.72B | 10.25B | 9.78B |
| COGS % of Revenue | 53.99% | 52.8% | 53.65% | 54.3% | 58.22% | 59.65% | 59.01% | 56.87% | 54.82% |
| Gross Profit | 8.18B▲ 0% | 8.55B▲ 4.6% | 7.95B▼ 7.1% | 7.91B▼ 0.5% | 7.17B▼ 9.4% | 7.19B▲ 0.4% | 7.45B▲ 3.5% | 7.77B▲ 4.4% | 8.06B▲ 3.7% |
| Gross Margin % | 46.01% | 47.2% | 46.35% | 45.7% | 41.78% | 40.35% | 40.99% | 43.13% | 45.18% |
| Gross Profit Growth % | -22.92% | 4.56% | -7.07% | -0.45% | -9.4% | 0.36% | 3.53% | 4.36% | 3.67% |
| Operating Expenses | 6.65B | 6.83B | 6.58B | 6.65B | 6.62B | 8.72B | 7.56B | 7.24B | 6.63B |
| OpEx % of Revenue | 37.42% | 37.72% | 38.39% | 38.4% | 38.56% | 48.93% | 41.63% | 40.2% | 37.2% |
| Selling, General & Admin | 4.97B | 5.13B | 4.56B | 4.55B | 4.86B | 5.29B | 5.13B | 5.07B | 4.97B |
| SG&A % of Revenue | 27.98% | 28.32% | 26.59% | 26.29% | 28.31% | 29.69% | 28.25% | 28.12% | 27.87% |
| Research & Development | 1.76B | 1.76B | 1.79B | 1.91B | 1.81B | 2.09B | 1.89B | 1.75B | 1.7B |
| R&D % of Revenue | 9.92% | 9.71% | 10.44% | 11.06% | 10.53% | 11.73% | 10.4% | 9.69% | 9.53% |
| Other Operating Expenses | 21M | 9M | 232M | 183M | -48M | 1.34B | 541M | 429M | -36M |
| Operating Income | 1.52B▲ 0% | 1.72B▲ 13.3% | 1.37B▼ 20.5% | 1.26B▼ 7.5% | 553M▼ 56.3% | -1.53B▼ 376.5% | -115M▲ 92.5% | 529M▲ 560.0% | 1.42B▲ 169.2% |
| Operating Margin % | 8.53% | 9.49% | 7.97% | 7.3% | 3.22% | -8.58% | -0.63% | 2.94% | 7.98% |
| Operating Income Growth % | -19.39% | 13.32% | -20.54% | -7.47% | -56.25% | -376.49% | 92.48% | 560% | 169.19% |
| EBITDA | 2.54B | 2.81B | 2.27B | 2.33B | 1.88B | 73M | 1.15B | 1.92B | 2.55B |
| EBITDA Margin % | 14.3% | 15.5% | 13.24% | 13.46% | 10.93% | 0.41% | 6.31% | 10.64% | 14.29% |
| EBITDA Growth % | -19.28% | 10.46% | -19.16% | 2.69% | -19.52% | -96.11% | 1469.86% | 67.36% | 32.9% |
| D&A (Non-Cash Add-back) | 1.02B | 1.09B | 904M | 1.07B | 1.32B | 1.6B | 1.26B | 1.39B | 1.13B |
| EBIT | 1.62B | 1.71B | 1.72B | 1.69B | 673M | -1.49B | -220M | 460M | 1.51B |
| Net Interest Income | -81M | -219M | -179.08M | -178.98M | -146M | -219M | -260M | -257M | -223.8M |
| Interest Income | 126M | 51M | 30.22M | 14.82M | 18M | 25M | 46M | 79M | 108.54M |
| Interest Expense | 263M | 264M | 209.3M | 193.8M | 164M | 244M | 306M | 337M | 332.34M |
| Other Income/Expense | -140M | -216M | -119M | -53M | -44M | -202M | -412M | -406M | -242M |
| Pretax Income | 1.38B▲ 0% | 1.5B▲ 9.2% | 1.25B▼ 17.0% | 1.21B▼ 2.9% | 509M▼ 58.0% | -1.73B▼ 440.1% | -527M▲ 69.6% | 123M▲ 123.3% | 1.18B▲ 861.0% |
| Pretax Margin % | 7.74% | 8.29% | 7.27% | 6.99% | 2.97% | -9.71% | -2.9% | 0.68% | 6.63% |
| Income Tax | 349M | 193M | 258M | 212M | -103M | -113M | -73M | 963M | 282M |
| Effective Tax Rate % | 25.34% | 12.84% | 20.69% | 17.51% | -20.24% | 6.53% | 13.85% | 782.93% | 23.86% |
| Net Income | 1.66B▲ 0% | 1.09B▼ 34.2% | 1.17B▲ 7.1% | 1.19B▲ 1.7% | 3.32B▲ 179.6% | -1.61B▼ 148.4% | -466M▲ 71.0% | -702M▼ 50.6% | 895M▲ 227.5% |
| Net Margin % | 9.32% | 6.02% | 6.81% | 6.86% | 19.35% | -9.02% | -2.56% | -3.9% | 5.02% |
| Net Income Growth % | 14.43% | -34.22% | 7.06% | 1.71% | 179.61% | -148.45% | 71.02% | -50.64% | 227.49% |
| Net Income (Continuing) | 1.03B | 1.31B | 989M | 999M | 612M | -1.62B | -454M | -840M | 900M |
| Discontinued Operations | 843M | 0 | 183M | 196M | 2.71B | 13M | -10M | 142M | -4M |
| Minority Interest | 24M | 29M | 28M | 31M | 36M | 34M | 33M | 37M | 32M |
| EPS (Diluted) | 1.64▲ 0% | 1.09▼ 33.5% | 1.20▲ 10.1% | 1.23▲ 2.5% | 0.64▼ 48.0% | -1.68▼ 362.5% | -0.49▲ 70.8% | -0.75▼ 53.1% | 0.93▲ 224.0% |
| EPS Growth % | 12.33% | -33.54% | 10.09% | 2.5% | -47.97% | -362.5% | 70.83% | -53.06% | 224% |
| EPS (Basic) | 1.67 | 1.11 | 1.21 | 1.25 | 0.67 | -1.68 | -0.49 | -0.75 | 0.95 |
| Diluted Shares Outstanding | 1.01B | 997.48M | 972.79M | 957.56M | 950.28M | 952.46M | 948.79M | 933.37M | 962.5M |
| Basic Shares Outstanding | 989.96M | 983.77M | 962.2M | 948.26M | 907.46M | 952.46M | 948.79M | 933.37M | 962.37M |
| Dividend Payout Ratio | 23.17% | 36.79% | 43.45% | 0.08% | 17.17% | - | - | - | 36.65% |
PHG Balance Sheet
Koninklijke Philips N.V. (PHG) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 10.12B | 9.57B | 9.46B | 11.23B | 10.35B | 10.26B | 9.94B | 10.02B | 9.93B |
| Cash & Short-Term Investments | 1.94B | 2.12B | 1.43B | 3.23B | 2.31B | 1.18B | 1.87B | 2.4B | 2.79B |
| Cash Only | 1.94B | 1.69B | 1.43B | 3.23B | 2.3B | 1.17B | 1.87B | 2.4B | 2.79B |
| Short-Term Investments | 2M | 436M | 1M | 0 | 2M | 11M | 3M | 2M | 0 |
| Accounts Receivable | 4.2B | 4.18B | 5.02B | 4.16B | 4.29B | 4.65B | 4.25B | 3.67B | 3.53B |
| Days Sales Outstanding | 86.3 | 84.24 | 106.84 | 87.64 | 91.23 | 95.27 | 85.4 | 74.37 | 72.25 |
| Inventory | 2.35B | 2.67B | 2.77B | 2.99B | 3.45B | 4.05B | 3.49B | 3.2B | 2.87B |
| Days Inventory Outstanding | 89.46 | 102.01 | 110.03 | 116.21 | 126.08 | 138.99 | 118.85 | 113.9 | 107.16 |
| Other Current Assets | 1.71B | 776M | 53M | 682M | 132M | 200M | 129M | 511M | 738M |
| Total Non-Current Assets | 15.2B | 16.45B | 17.56B | 16.49B | 20.61B | 20.43B | 19.47B | 18.95B | 17.01B |
| Property, Plant & Equipment | 1.59B | 1.71B | 2.87B | 2.68B | 2.7B | 2.64B | 2.48B | 2.45B | 2.22B |
| Fixed Asset Turnover | 11.18x | 10.58x | 5.98x | 6.46x | 6.36x | 6.76x | 7.31x | 7.35x | 8.04x |
| Goodwill | 7.73B | 8.5B | 8.65B | 8.01B | 10.64B | 10.24B | 9.88B | 10.38B | 9.27B |
| Intangible Assets | 3.32B | 3.59B | 3.47B | 3B | 3.65B | 3.53B | 3.19B | 2.98B | 2.57B |
| Long-Term Investments | 729M | 604M | 481M | 670M | 1.06B | 1.2B | 1B | 889M | 852M |
| Other Non-Current Assets | 227M | 211M | 225M | 303M | 355M | 381M | 287M | 332M | 2.1B |
| Total Assets | 25.32B▲ 0% | 26.02B▲ 2.8% | 27.02B▲ 3.8% | 27.71B▲ 2.6% | 30.96B▲ 11.7% | 30.69B▼ 0.9% | 29.41B▼ 4.2% | 28.98B▼ 1.5% | 26.94B▼ 7.0% |
| Asset Turnover | 0.70x | 0.70x | 0.63x | 0.62x | 0.55x | 0.58x | 0.62x | 0.62x | 0.66x |
| Asset Growth % | -21.63% | 2.78% | 3.83% | 2.58% | 11.72% | -0.88% | -4.18% | -1.46% | -7.01% |
| Total Current Liabilities | 6.87B | 7.94B | 6.98B | 7.74B | 7.45B | 7.93B | 8.29B | 8.14B | 7.51B |
| Accounts Payable | 2.09B | 2.3B | 2.09B | 2.12B | 1.87B | 1.97B | 1.92B | 1.83B | 1.93B |
| Days Payables Outstanding | 79.46 | 87.85 | 82.89 | 82.27 | 68.41 | 67.56 | 65.26 | 65.18 | 71.95 |
| Short-Term Debt | 585M | 1.3B | 110M | 962M | 53M | 95M | 123M | 224M | 1.15B |
| Deferred Revenue (Current) | 372M | 878M | 1.17B | 1.24B | 1.49B | 1.7B | 1.81B | 1.7B | 0 |
| Other Current Liabilities | 1.96B | 2.09B | 937M | 785M | 1.39B | 1.95B | 1.93B | 2.19B | 2.81B |
| Current Ratio | 1.47x | 1.21x | 1.36x | 1.45x | 1.39x | 1.29x | 1.20x | 1.23x | 1.32x |
| Quick Ratio | 1.13x | 0.87x | 0.96x | 1.06x | 0.93x | 0.78x | 0.78x | 0.84x | 0.94x |
| Cash Conversion Cycle | 96.3 | 98.39 | 133.98 | 121.57 | 148.89 | 166.7 | 138.99 | 123.1 | 107.45 |
| Total Non-Current Liabilities | 6.43B | 5.96B | 7.41B | 8.08B | 9.04B | 9.47B | 9.06B | 8.79B | 8.45B |
| Long-Term Debt | 3.85B | 3.19B | 3.77B | 4.76B | 4.77B | 6.17B | 6.09B | 6.19B | 6.93B |
| Capital Lease Obligations | 195M | 236M | 1.11B | 948M | 963M | 852M | 864M | 854M | 0 |
| Deferred Tax Liabilities | 33M | 152M | 143M | 59M | 83M | 91M | 71M | 81M | 0 |
| Other Non-Current Liabilities | 2.1B | 2.53B | 2.05B | 1.91B | 2.77B | 1.85B | 1.56B | 1.23B | 1.51B |
| Total Liabilities | 13.29B | 13.9B | 14.39B | 15.81B | 16.49B | 17.41B | 17.34B | 16.93B | 15.96B |
| Total Debt | 4.72B | 4.82B | 5.26B | 6.93B | 6.05B | 7.34B | 7.29B | 7.49B | 8.09B |
| Net Debt | 2.78B | 3.13B | 3.83B | 3.71B | 3.74B | 6.17B | 5.42B | 5.09B | 5.29B |
| Debt / Equity | 0.39x | 0.40x | 0.42x | 0.58x | 0.42x | 0.55x | 0.60x | 0.62x | 0.74x |
| Debt / EBITDA | 1.86x | 1.72x | 2.32x | 2.97x | 3.22x | 100.58x | 6.36x | 3.91x | 3.17x |
| Net Debt / EBITDA | 1.09x | 1.12x | 1.69x | 1.59x | 2.00x | 84.52x | 4.73x | 2.65x | 2.08x |
| Interest Coverage | 6.16x | 6.46x | 8.22x | 8.69x | 4.10x | -6.09x | -0.72x | 1.36x | 4.56x |
| Total Equity | 12.02B▲ 0% | 12.12B▲ 0.8% | 12.63B▲ 4.2% | 11.9B▼ 5.7% | 14.47B▲ 21.6% | 13.28B▼ 8.2% | 12.06B▼ 9.2% | 12.04B▼ 0.1% | 10.99B▼ 8.8% |
| Equity Growth % | -10.99% | 0.78% | 4.19% | -5.73% | 21.63% | -8.23% | -9.2% | -0.15% | -8.75% |
| Book Value per Share | 11.94 | 12.15 | 12.98 | 12.43 | 15.23 | 13.95 | 12.71 | 12.90 | 11.42 |
| Total Shareholders' Equity | 12B | 12.09B | 12.6B | 11.87B | 14.44B | 13.25B | 12.03B | 12.01B | 10.96B |
| Common Stock | 188M | 185M | 179M | 182M | 177M | 178M | 183M | 188M | 193M |
| Retained Earnings | 8.6B | 8.27B | 8.3B | 7.83B | 9.34B | 6.83B | 5.4B | 3.65B | 3.58B |
| Treasury Stock | -481M | -399M | -201M | -199M | -476M | -275M | -262M | -411M | -298M |
| Accumulated OCI | 11.81B | 11.9B | 652M | -340M | 748M | 1.49B | 879M | 1.93B | 274M |
| Minority Interest | 24M | 29M | 28M | 31M | 36M | 34M | 33M | 37M | 32M |
PHG Cash Flow Statement
Koninklijke Philips N.V. (PHG) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 1.87B | 1.78B | 2.27B | 2.64B | 1.93B | -181.82M | 2.31B | 1.7B | 1.16B |
| Operating CF Margin % | 10.52% | 9.82% | 13.26% | 15.25% | 11.23% | -1.02% | 12.71% | 9.42% | 6.52% |
| Operating CF Growth % | -1.79% | -4.81% | 27.71% | 16.14% | -27.02% | -109.44% | 1370.09% | -26.51% | -31.53% |
| Net Income | 1.03B | 1.31B | 1.33B | 1.19B | 718.64M | -1.7B | -492.99M | -912.95M | 895M |
| Depreciation & Amortization | 1.02B | 1.09B | 1.09B | 1.46B | 1.24B | 1.26B | 1.39B | 1.26B | 1.13B |
| Stock-Based Compensation | 122M | 102M | 0 | 112M | 0 | 0 | 0 | 0 | 141M |
| Deferred Taxes | 349M | 193M | 0 | 284M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.46B | 962M | 609.99M | 131M | 143.02M | 1.5B | -98.38M | 1.35B | 330M |
| Working Capital Changes | -509M | -500M | -755.49M | -536M | -179.66M | -1.24B | 1.51B | 7.57M | -1.33B |
| Change in Receivables | 64M | -97M | 0 | 92M | 0 | -359.43M | 322.17M | -1.08M | -9M |
| Change in Inventory | -144M | -394M | -195.87M | -578M | -686.73M | -601.16M | 277.85M | 248.79M | -115M |
| Change in Payables | 0 | 0 | -413M | 0 | 258.85M | 54.65M | 387.04M | -630.63M | 0 |
| Cash from Investing | -3.2B | -1.49B | -702.89M | -1.27B | -317.95M | -1.58B | -553.53M | -633.87M | -737M |
| Capital Expenditures | -859M | -843M | -1.13B | -895M | -901.85M | -847.09M | -695.16M | -731.22M | -269M |
| CapEx % of Revenue | 4.83% | 4.65% | 6.61% | 5.17% | 5.26% | 4.75% | 3.83% | 4.06% | 1.51% |
| Acquisitions | -2.28B | -558M | -82.82M | -313M | -3.5B | -600.11M | 104.87M | 141.7M | -3M |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -463M | -549M | -27.98M | 20M | 4.02B | -12.61M | 134.06M | 27.04M | -465M |
| Cash from Financing | 55M | -1.19B | -1.86B | 483M | -2.77B | 525.49M | -916.79M | -536.52M | 107M |
| Debt Issued (Net) | -217M | 126M | 122M | 767M | -296.68M | 1.15B | -195.68M | -88.7M | 448M |
| Equity Issued (Net) | -642M | -1.04B | -1.48B | -343M | -1.91B | -183.92M | -715.7M | -444.57M | 0 |
| Dividends Paid | -384M | -401M | -507.02M | -1M | -569.71M | -433M | -2.16M | -1.08M | -328M |
| Share Repurchases | -642M | -1.04B | -1.54B | -343M | -1.93B | -196.53M | -715.7M | -444.57M | 0 |
| Other Financing | 1.3B | 125M | -2.24M | 60M | -2.36M | -6.31M | -3.24M | -2.16M | -13M |
| Net Change in Cash | -395M▲ 0% | -251M▲ 36.5% | -330.07M▼ 31.5% | 1.8B▲ 645.6% | -1.33B▼ 173.7% | -1.37B▼ 3.0% | 813.77M▲ 159.5% | 421.64M▼ 48.2% | 393M▼ 6.8% |
| Free Cash Flow | 1.01B▲ 0% | 937M▼ 7.3% | 1.69B▲ 80.7% | 2.15B▲ 27.3% | 1.46B▼ 32.4% | -648.45M▼ 144.5% | 1.94B▲ 398.8% | 1.35B▼ 30.1% | 893M▼ 34.1% |
| FCF Margin % | 5.69% | 5.17% | 9.88% | 12.45% | 8.49% | -3.64% | 10.66% | 7.51% | 5.01% |
| FCF Growth % | -2.32% | -7.32% | 80.73% | 27.26% | -32.37% | -144.49% | 398.77% | -30.1% | -34.06% |
| FCF per Share | 1.00 | 0.94 | 1.74 | 2.25 | 1.53 | -0.68 | 2.04 | 1.45 | 0.93 |
| FCF Conversion (FCF/Net Income) | 1.13x | 1.63x | 1.95x | 2.22x | 0.58x | 0.11x | -4.96x | -2.42x | 1.30x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 253M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PHG Key Ratios
Koninklijke Philips N.V. (PHG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 11.45% | 12.98% | 9.03% | 9.43% | 9.68% | 25.17% | -11.59% | -3.68% | -5.82% | 7.77% |
| Return on Invested Capital (ROIC) | 8.67% | 7.21% | 8.58% | 6.46% | 5.91% | 2.45% | -6.09% | -0.47% | 2.29% | 6.39% |
| Gross Margin | 43.29% | 46.01% | 47.2% | 46.35% | 45.7% | 41.78% | 40.35% | 40.99% | 43.13% | 45.18% |
| Net Margin | 5.91% | 9.32% | 6.02% | 6.81% | 6.86% | 19.35% | -9.02% | -2.56% | -3.9% | 5.02% |
| Debt / Equity | 0.42x | 0.39x | 0.40x | 0.42x | 0.58x | 0.42x | 0.55x | 0.60x | 0.62x | 0.74x |
| Interest Coverage | 2.42x | 6.16x | 6.46x | 8.22x | 8.69x | 4.10x | -6.09x | -0.72x | 1.36x | 4.56x |
| FCF Conversion | 1.31x | 1.13x | 1.63x | 1.95x | 2.22x | 0.58x | 0.11x | -4.96x | -2.42x | 1.30x |
| Revenue Growth | 1.12% | -27.48% | 1.92% | -5.38% | 0.97% | -0.91% | 3.91% | 1.92% | -0.81% | -1.04% |
PHG Frequently Asked Questions
Koninklijke Philips N.V. (PHG) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Koninklijke Philips N.V. (PHG) reported $17.83B in revenue for fiscal year 2025. This represents a 44% decrease from $31.92B in 1996.
Koninklijke Philips N.V. (PHG) saw revenue decline by 1.0% over the past year.
Yes, Koninklijke Philips N.V. (PHG) is profitable, generating $895.0M in net income for fiscal year 2025 (5.0% net margin).
Dividend & Returns
Yes, Koninklijke Philips N.V. (PHG) pays a dividend with a yield of 1.47%. This makes it attractive for income-focused investors.
Koninklijke Philips N.V. (PHG) has a return on equity (ROE) of 7.8%. This is below average, suggesting room for improvement.
Koninklijke Philips N.V. (PHG) generated $755.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More PHG
Koninklijke Philips N.V. (PHG) financial analysis — history, returns, DCA and operating performance tools
Full PHG Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates